Specific immunotherapy using Hymenoptera venom: systematic review

This is the authors' abstract. We don't add key points for this paper.

Specific immunotherapy should be recommended for adults and children with moderate to severe reactions, but there is no need to prescribe it for children with skin reactions alone, especially if the exposure is very sporadic. On the other hand, the risk-benefit relation should always be assessed in each case.